GRK5 and triple-negative breast carcinoma: In order to further investigate the function of GRK5 in triple-negative breast cancer (TNBC), MDA-MB-231 cells stably expressing a doxycycline inducible shGRK5 were generated (termed MDA-MB-231 TRIPZ-shGRK5 in the following).